443 related articles for article (PubMed ID: 16041837)
1. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
Adamec J; Waisser K; Kunes J; Kaustová J
Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
Sriram D; Yogeeswari P; Madhu K
Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
[TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of diphenylpyraline derivatives.
Weis R; Faist J; di Vora U; Schweiger K; Brandner B; Kungl AJ; Seebacher W
Eur J Med Chem; 2008 Apr; 43(4):872-9. PubMed ID: 17714832
[TBL] [Abstract][Full Text] [Related]
4. 2(3H)-furanones and 2(3H)-pyrrolones: synthesis and antimycobacterial evaluation.
Husain A; Alam MM; Hasan SM; Yar MS
Acta Pol Pharm; 2009; 66(2):173-80. PubMed ID: 19719052
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
[TBL] [Abstract][Full Text] [Related]
6. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
Ali MA; Yar MS
Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
Sirisha K; Bikshapathi D; Achaiah G; Reddy VM
Eur J Med Chem; 2011 May; 46(5):1564-71. PubMed ID: 21382653
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines.
Bakkestuen AK; Gundersen LL; Utenova BT
J Med Chem; 2005 Apr; 48(7):2710-23. PubMed ID: 15801862
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
12. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
Segura-Cabrera A; Rodríguez-Pérez MA
Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
[TBL] [Abstract][Full Text] [Related]
13. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings.
Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M
J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitubercular activity of ferrocenyl diaminoalcohols and diamines.
Andrianina Ralambomanana D; Razafimahefa-Ramilison D; Rakotohova AC; Maugein J; Pélinski L
Bioorg Med Chem; 2008 Nov; 16(21):9546-53. PubMed ID: 18835177
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of 1-substituted indolizines.
Gundersen LL; Negussie AH; Rise F; ØStby OB
Arch Pharm (Weinheim); 2003 Jun; 336(3):191-5. PubMed ID: 12822185
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
Němeček J; Sychra P; Macháček M; Benková M; Karabanovich G; Konečná K; Kavková V; Stolaříková J; Hrabálek A; Vávrová K; Soukup O; Roh J; Klimešová V
Eur J Med Chem; 2017 Apr; 130():419-432. PubMed ID: 28279848
[TBL] [Abstract][Full Text] [Related]
17. New class of methyl tetrazole based hybrid of (Z)-5-benzylidene-2-(piperazin-1-yl)thiazol-4(%H)-one as potent antitubercular agents.
Chauhan K; Sharma M; Trivedi P; Chaturvedi V; Chauhan PM
Bioorg Med Chem Lett; 2014 Sep; 24(17):4166-70. PubMed ID: 25127167
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimycobacterial activity of ferrocenyl ethambutol analogues and ferrocenyl diamines.
Razafimahefa D; Ralambomanana DA; Hammouche L; Pélinski L; Lauvagie S; Bebear C; Brocard J; Maugein J
Bioorg Med Chem Lett; 2005 May; 15(9):2301-3. PubMed ID: 15837313
[TBL] [Abstract][Full Text] [Related]
20. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]